Monday, July 13, 1998
For years, scientists have been trying with little success to separate
the psychoactive properties of marijuana from its potential medical uses. Likewise,
researchers have had limited success seeking molecules to neutralize reactive oxygen to
protect tissues, most notably with therapeutic candidates based on superoxide dismutase.
But the two frustrating lines of research are apparently converging on cannabidiol, a
non-psychogenic marijuana molecule.
Research published in The Proceedings of the National Academy of
Sciences highlights the anti-ischemic properties of cannabidiol. THC
(tetrahydrocannabinol, the psychoactive ingredient in marijuana) and cannabidiol had equal
effectiveness in blocking